You just read:

European Commission Approves Expanded Use Of Mimpara® (Cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Children With End-Stage Renal Disease On Dialysis

News provided by

Amgen

Aug 31, 2017, 16:00 ET